Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012044747
Tue, 05.11.2024
Redcare Pharmacy N.V.
Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
Total Group sales growth 21% in Q3 to EUR 575M and 34% year to date to EUR 1.7bn after nine months.
Non-Rx sales growth 20% in Q3 to EUR 383M (9M growth 20% to EUR 1.2bn); Rx sales growth 23% [ … ]
Thu, 03.10.2024
Redcare Pharmacy N.V.
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Q3 total Group sales up 21% year over year to EUR 574M and year to date 34% to EUR 1.7bn; non-Rx sales growth 20% year over year to EUR 383M and also 20% year to date to EUR 1.2bn.
Active cus [ … ]
Thu, 03.10.2024
Redcare Pharmacy N.V.
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Sevenum, the Netherlands, 3 October 2024. The Management Board of Redcare Pharmacy has decided to intensify marketing investments for its e-Rx business in Ger [ … ]
Tue, 30.07.2024
Redcare Pharmacy N.V.
Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.
Total sales of over EUR 1.1 bn after six months, up 42%, with Q2 year-over-year growth of 34% to EUR 561M.
H1 non-Rx sales of EUR 795M (+20%); EUR 391M in Q2 (+21%).
Total Rx sales of EUR [ … ]
Thu, 04.07.2024
Redcare Pharmacy N.V.
Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2.
Total sales reached EUR 560M in Q2, up 33% year over year.
Non-Rx sales totaled EUR 390M, steady continuation of fast growth, up 21% year over year.
Rx sales increased to EUR 50M in Germany, 37% growth in Q2 year over year, while CardLink was la [ … ]
Mon, 06.05.2024
Redcare Pharmacy N.V.
Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
Fully digital redemption method via eGK health card and smartphone.
Secure, easy and comfortable way to redeem e-prescriptions.
Technically integrated within Redcare’s Shop Apotheke mobile app in Germany.
Sevenum, the [ … ]
Thu, 25.04.2024
Redcare Pharmacy N.V.
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
Group sales of EUR 560M in Q1, up 51% from prior year.
Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns.
Adj. EBITDA ma [ … ]
Tue, 23.04.2024
Redcare Pharmacy N.V.
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Fully digital redemption method to be integrated in Redcare’s Shop Apotheke mobile app in Germany.
Expected to be available for customers by early May.
Redcare ideally positioned to serve e-Rx customers in the multi-billion-euro German prescription market.
Sevenum, the Neth [ … ]
Tue, 23.04.2024
Redcare Pharmacy N.V.
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using thei [ … ]
Thu, 18.04.2024
Redcare Pharmacy N.V.
Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
Sevenum, the Netherlands, 18 April, 2024. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of Dirk Brüse [ … ]